Hagop M Kantarjian Selected Research

Hagop M Kantarjian Research Topics

Disease

160	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2024 - 06/2002
142	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 05/2024 - 03/2002
104	Neoplasms (Cancer) 03/2024 - 07/2002
94	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 05/2024 - 01/2002
85	Philadelphia Chromosome 05/2024 - 04/2002
78	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 03/2024 - 05/2002
75	Leukemia 05/2024 - 02/2002
33	Primary Myelofibrosis (Myelosclerosis) 04/2024 - 04/2003
26	Hematologic Neoplasms (Hematological Malignancy) 01/2020 - 01/2002
21	Blast Crisis (Blast Phase) 01/2024 - 05/2002
20	Residual Neoplasm 05/2024 - 01/2003
20	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 04/2003
19	Thrombocytopenia (Thrombopenia) 01/2023 - 09/2002
16	Neutropenia 01/2024 - 06/2003
15	Disease Progression 05/2024 - 03/2002
15	Anemia 04/2024 - 04/2002
13	Acute Promyelocytic Leukemia 12/2023 - 06/2002
13	Infections 01/2023 - 01/2002
12	Myeloid Leukemia (Leukemia, Myelocytic) 01/2020 - 06/2002
11	Fibrosis (Cirrhosis) 01/2022 - 07/2005
11	Exanthema (Rash) 01/2021 - 03/2003
11	Diarrhea 01/2019 - 08/2002
11	Splenomegaly 01/2019 - 10/2004
10	Chromosome Aberrations (Chromosome Abnormalities) 01/2023 - 04/2004
9	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 03/2024 - 04/2003
9	Lymphoma (Lymphomas) 01/2019 - 12/2003
8	Fatigue 01/2021 - 04/2003
8	Polycythemia Vera 01/2017 - 06/2006
7	Febrile Neutropenia 11/2021 - 07/2012
7	Pleural Effusion (Pleural Effusions) 01/2020 - 06/2005
6	Hairy Cell Leukemia 05/2024 - 12/2003
6	Pneumonia (Pneumonitis) 01/2022 - 09/2007
6	Cytopenia 01/2021 - 05/2006
6	Pathologic Complete Response 01/2019 - 06/2002
5	Edema (Dropsy) 01/2019 - 08/2002
5	Fever (Fevers) 01/2018 - 06/2005
5	Essential Thrombocythemia 10/2017 - 06/2006
5	Myeloproliferative Disorders (Myeloproliferative Disorder) 06/2006 - 04/2003

Drug/Important Bio-Agent (IBA)

91	Imatinib Mesylate (Gleevec)FDA Link 05/2024 - 03/2002
75	Tyrosine Kinase InhibitorsIBA 05/2024 - 09/2003
50	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2024 - 04/2002
35	Decitabine FDA Link 12/2021 - 08/2003
34	venetoclaxIBA 01/2024 - 12/2015
33	Proteins (Proteins, Gene)FDA Link 01/2023 - 06/2002
33	Dasatinib (BMS 354825)FDA Link 05/2022 - 02/2007
27	nilotinib FDA Link 07/2021 - 02/2007
26	Azacitidine (5 Azacytidine)FDA Link 01/2023 - 05/2002
22	ruxolitinibIBA 10/2020 - 01/2009
21	Inotuzumab OzogamicinIBA 03/2024 - 08/2016
19	Phosphotransferases (Kinase)IBA 01/2019 - 11/2005
18	blinatumomabIBA 06/2023 - 03/2014
15	Rituximab (Mabthera)FDA Link 05/2024 - 04/2003
15	Clofarabine (Clolar)FDA Link 02/2017 - 03/2003
14	bosutinibIBA 01/2024 - 05/2011
13	ponatinibIBA 05/2024 - 06/2013
13	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 01/2002
13	Vincristine (Oncovin)FDA LinkGeneric 01/2021 - 01/2002
13	bcr-abl Fusion ProteinsIBA 01/2020 - 03/2002
12	Monoclonal AntibodiesIBA 11/2023 - 04/2003
12	NucleosidesIBA 01/2023 - 02/2002
12	fludarabineIBA 01/2022 - 04/2002
12	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 08/2021 - 06/2002
12	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021 - 01/2002
10	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 06/2002
9	Interferon-alpha (Interferon Alfa)IBA 02/2008 - 04/2002
8	enasidenibIBA 01/2023 - 10/2017
8	Reticulin (Reticular Fiber)IBA 01/2022 - 07/2005
8	Lenalidomide (CC 5013)FDA Link 01/2021 - 08/2006
8	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 01/2002
8	CytokinesIBA 01/2020 - 07/2003
7	Arsenic Trioxide (Trisenox)FDA Link 12/2023 - 09/2004
7	Hemoglobins (Hemoglobin)IBA 11/2023 - 04/2002
7	MethyltransferasesIBA 01/2023 - 08/2007
7	Gemtuzumab (Mylotarg)FDA Link 01/2022 - 06/2002
7	Methotrexate (Mexate)FDA LinkGeneric 01/2018 - 04/2003
6	Cladribine FDA LinkGeneric 05/2024 - 06/2006
6	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2022 - 06/2002
6	Core Binding Factors (Core-Binding Factor)IBA 01/2022 - 05/2009
6	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2021 - 01/2002
6	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020 - 05/2002
6	Transaminases (Aminotransferases)IBA 01/2020 - 01/2008
6	Janus Kinase 2IBA 01/2019 - 11/2005
6	Janus Kinase InhibitorsIBA 02/2014 - 01/2013
6	troxacitabineIBA 01/2007 - 02/2002
5	ivosidenibIBA 02/2024 - 01/2020
5	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2023 - 10/2017
5	EnzymesIBA 01/2023 - 11/2002
5	fms-Like Tyrosine Kinase 3IBA 01/2022 - 10/2012
5	NucleophosminIBA 01/2021 - 10/2009
5	Histone Deacetylase InhibitorsIBA 12/2017 - 11/2006
5	InterferonsIBA 01/2017 - 06/2003
5	HomoharringtonineIBA 01/2016 - 04/2002
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2004 - 11/2002

Therapy/Procedure

223	Therapeutics 03/2024 - 04/2002
63	Drug Therapy (Chemotherapy) 03/2024 - 01/2002
14	Salvage Therapy 01/2021 - 10/2008
12	Stem Cell Transplantation 12/2019 - 09/2002
10	Induction Chemotherapy 01/2022 - 01/2002
9	Drug Tapering 01/2020 - 06/2003
8	Aftercare (After-Treatment) 01/2023 - 08/2002